Charles Sawyers

Non Executive / Other Non-Executive
  • Director Verified:
  • No
Login/ Register  to follow report
Company:

About

Charles L. Sawyers is a highly accomplished expert and leader in cancer research. As a physician and prominent scientist, he has a deep understanding of the benefits of drugs for patients and society at large, and the importance of access to medicines. Dr. Sawyers co-developed the Novartis cancer drug Gleevec/ Glivec and has received numerous honors and awards, including the Lasker-DeBakey Clinical Medical Research Award. Currently he is Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, US (2006–present); a Professor of medicine (2008–present), and professor of cell and developmental biology (2011–present) at Weill Cornell Graduate School of Medical Sciences, US; an Investigator, Howard Hughes Medical Institute, US (2002–2006 and 2008–present); a Member at National Academy of Medicine, US; a Member at National Academy of Sciences, US; an Investigator at Howard Hughes Medical Institute, US; and a Science advisor for the following US companies: Arsenal Capital Partners; BeiGene Ltd.; Blueprint
Medicines Corp.; Foghorn Therapeutics Inc.; Housey Pharmaceutical Research Laboratories; KSQ Therapeutics Inc.; Nextech Invest Ltd.; ORIC Pharmaceuticals Inc.; PMV Pharmaceuticals Inc.; and The Column Group. Previously he was an Associate chief, Division of Hematology-Oncology at University of California, Los Angeles, US (1996–2006); a Member at National Cancer Advisory Board, US (2012–2020); and a President of American Association for Cancer Research, US (2013–2014). He has a Doctor of medicine from Johns Hopkins University School of Medicine, US and a Bachelor of Arts, Princeton University, US.

 

Personal Details

Title: Dr
Surname: Sawyers
DoB: 01/01/1959
Age: 67 years
M/F: Male
Nationality: American
Country of Birth: American
Language: English
Qualification: M.D, BA
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

CompanyCommitteePositionDate Appointed
BoardOther Official01/01/2006
BoardOther Official01/01/2011
BoardOther Official01/01/2008
BoardMember
BoardMember

 

Working history

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
NovartisBoardMember01/01/2013
NovartisNominations & GovernanceMember01/01/2013
NovartisTechnologyMember01/01/2013

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF